Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

157 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Quality of web-based information on inflammatory bowel diseases.
van der Marel S, Duijvestein M, Hardwick JC, van den Brink GR, Veenendaal R, Hommes DW, Fidder HH. van der Marel S, et al. Among authors: van den brink gr. Inflamm Bowel Dis. 2009 Dec;15(12):1891-6. doi: 10.1002/ibd.20976. Epub 2009 May 21. Inflamm Bowel Dis. 2009. PMID: 19462423
Loss of Indian Hedgehog activates multiple aspects of a wound healing response in the mouse intestine.
van Dop WA, Heijmans J, Büller NV, Snoek SA, Rosekrans SL, Wassenberg EA, van den Bergh Weerman MA, Lanske B, Clarke AR, Winton DJ, Wijgerde M, Offerhaus GJ, Hommes DW, Hardwick JC, de Jonge WJ, Biemond I, van den Brink GR. van Dop WA, et al. Among authors: van den bergh weerman ma, van den brink gr. Gastroenterology. 2010 Nov;139(5):1665-76, 1676.e1-10. doi: 10.1053/j.gastro.2010.07.045. Epub 2010 Aug 1. Gastroenterology. 2010. PMID: 20682322
Biosimilars in IBD: hope or expectation?
Gecse KB, Khanna R, van den Brink GR, Ponsioen CY, Löwenberg M, Jairath V, Travis SP, Sandborn WJ, Feagan BG, D'Haens GR. Gecse KB, et al. Among authors: van den brink gr. Gut. 2013 Jun;62(6):803-7. doi: 10.1136/gutjnl-2012-303824. Epub 2013 Mar 16. Gut. 2013. PMID: 23503043 Review. No abstract available.
Effects of infliximab retreatment after consecutive discontinuation of infliximab and adalimumab in refractory Crohn's disease.
Brandse JF, Peters CP, Gecse KB, Eshuis EJ, Jansen JM, Tuynman HA, Löwenberg M, Ponsioen CY, van den Brink GR, DʼHaens GR; North Holland GUT Club. Brandse JF, et al. Among authors: van den brink gr. Inflamm Bowel Dis. 2014 Feb;20(2):251-8. doi: 10.1097/01.MIB.0000438248.14218.1d. Inflamm Bowel Dis. 2014. PMID: 24378599 Clinical Trial.
Serum Concentration of Anti-TNF Antibodies, Adverse Effects and Quality of Life in Patients with Inflammatory Bowel Disease in Remission on Maintenance Treatment.
Brandse JF, Vos LM, Jansen J, Schakel T, Ponsioen CI, van den Brink GR, D'Haens GR, Löwenberg M. Brandse JF, et al. Among authors: van den brink gr. J Crohns Colitis. 2015 Nov;9(11):973-81. doi: 10.1093/ecco-jcc/jjv116. Epub 2015 Jun 26. J Crohns Colitis. 2015. PMID: 26116557 Clinical Trial.
157 results